Determining the feasibility of linked claims and vaccination data for a Covid-vaccine pharmaco-epidemiological study in Germany – RiCO feasibility study protocol

Nina Timmesfeld, Peter Ihle, Robin Denz, Katharina Meiszl, Katrin Scholz, Doris Oberle, Ursula Drechsel-Bäuerle, Brigitte Keller-Stanislawski, Hans H. Diebner, Ingo Meyer
doi: https://doi.org/10.1101/2024.03.04.24303714

Article usage

Article usage: March 2024 to November 2024

AbstractFullPdf
Mar 20245541798
Apr 2024721011
May 20241042124
Jun 20243889
Jul 202433114
Aug 20241011423
Sep 202433911
Oct 202420612
Nov 20242929
Back to top
Posted March 07, 2024.
Download PDF
Data/Code
Email
Determining the feasibility of linked claims and vaccination data for a Covid-vaccine pharmaco-epidemiological study in Germany – RiCO feasibility study protocol
Nina Timmesfeld, Peter Ihle, Robin Denz, Katharina Meiszl, Katrin Scholz, Doris Oberle, Ursula Drechsel-Bäuerle, Brigitte Keller-Stanislawski, Hans H. Diebner, Ingo Meyer
medRxiv 2024.03.04.24303714; doi: https://doi.org/10.1101/2024.03.04.24303714
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area